Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CYB5R1 (1-305) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CYB5R1 |
Gene ID: |
51706 |
Uniprot ID: |
NB5R1_HUMAN |
Immunogen Region: |
1-305 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-305 of human CYB5R1 (NP_057327.2). |
Immunogen Sequence: |
MGIQTSPVLLASLGVGLVTL LGLAVGSYLVRRSRRPQVTL LDPNEKYLLRLLDKTTVSHN TKRFRFALPTAHHTLGLPVG KHIYLSTRIDGSLVIRPYTP VTSDEDQGYVDLVIKVYLKG VHPKFPEGGKMSQYLDSLKV GDVVEFRGPSGLLTYTGKGH FNIQPNKKSPPEPRVAKKLG MIAGGTGITPMLQLIRAILK VPEDPTQCFLLFANQTEKDI ILREDLEELQARYPNRFKL |
Tissue Specificity | Widely expressed. |
Function | NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction. |
Protein Name | Nadh-Cytochrome B5 Reductase 1B5r.1Humb5r2Nad(Ph -Quinone Oxidoreductase Type 3 Polypeptide A2 |
Database Links | Reactome: R-HSA-114608Reactome: R-HSA-1237044 |
Cellular Localisation | MembraneSingle-Pass Membrane Protein |
Alternative Antibody Names | Anti-Nadh-Cytochrome B5 Reductase 1 antibodyAnti-B5r.1 antibodyAnti-Humb5r2 antibodyAnti-Nad(Ph -Quinone Oxidoreductase Type 3 Polypeptide A2 antibodyAnti-CYB5R1 antibodyAnti-NQO3A2 antibodyAnti-UNQ3049 antibodyAnti-PRO9865 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance